These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4905530)

  • 21. Genetic evidence for an activator required for induction of colicin-like bacteriocin 28b production in Serratia marcescens by DNA-damaging agents.
    Ferrer S; Viejo MB; Guasch JF; Enfedaque J; Regué M
    J Bacteriol; 1996 Feb; 178(4):951-60. PubMed ID: 8576068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene dosage studies with pleiotropic mutants of Serratia marcescens superactive in the synthesis of marcescin A and certain other exocellular proteins.
    Timmis K; Winkler U
    Mol Gen Genet; 1973 Aug; 124(3):207-17. PubMed ID: 4584941
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory effect of bacteriocin produced by Lactobacillus acidophilusATCC 4356 and Lactobacillus plantarum ATCC 8014 on planktonic cells and biofilms of Serratia marcescens.
    Vahedi Shahandashti R; Kasra Kermanshahi R; Ghadam P
    Turk J Med Sci; 2016 Jun; 46(4):1188-96. PubMed ID: 27513424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 17 kDa outer-membrane protein (Omp4) from Serratia marcescens confers partial resistance to bacteriocin 28b when expressed in Escherichia coli.
    Guasch JF; Ferrer S; Enfedaque J; Viejo MB; Regué M
    Microbiology (Reading); 1995 Oct; 141 ( Pt 10)():2535-42. PubMed ID: 7582013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential action of a streptococcal bacteriocin on mycoplasmas and microbial L-forms.
    Harwick HJ; Montgomerie JZ; Kalamanson GM; Hubert EG; Potter CS; Guze LB
    Infect Immun; 1971 Sep; 4(3):194-8. PubMed ID: 5005294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli.
    Gordon DM; O'Brien CL
    Microbiology (Reading); 2006 Nov; 152(Pt 11):3239-3244. PubMed ID: 17074895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of action of pesticin.
    Elgat M; Ben-Gurion R
    J Bacteriol; 1969 May; 98(2):359-67. PubMed ID: 4891253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and characterization of two Serratia marcescens genes involved in core lipopolysaccharide biosynthesis.
    Guasch JF; Piqué N; Climent N; Ferrer S; Merino S; Rubires X; Tomas JM; Regué M
    J Bacteriol; 1996 Oct; 178(19):5741-7. PubMed ID: 8824620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A gene (wbbL) from Serratia marcescens N28b (O4) complements the rfb-50 mutation of Escherichia coli K-12 derivatives.
    Rubirés X; Saigi F; Piqué N; Climent N; Merino S; Albertí S; Tomás JM; Regué M
    J Bacteriol; 1997 Dec; 179(23):7581-6. PubMed ID: 9393727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteriocin (marcescin) typing of Serratia marcescens. II. The distribution of Serratia marcescens in hospital and its isolated cases by bacteriocin (marcescin) typing (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1978 Jun; 52(6):183-9. PubMed ID: 101627
    [No Abstract]   [Full Text] [Related]  

  • 35. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and mode of action of two bacteriocins produced by Serratia marcesens HY.
    Eichenlaub R; Winkler U
    J Gen Microbiol; 1974 Jul; 83(0):83-94. PubMed ID: 4606968
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on group A bacteriocins of Serratia marcescens: preliminary characterization of two subgroups of bacteriocins.
    Traub WH
    Zentralbl Bakteriol Orig A; 1972 Nov; 222(2):232-44. PubMed ID: 4144799
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of transferability of R-plasmid in bacteriocin-producing donors to bacteriocin-resistant recipients.
    Usui M; Hiki M; Murakami K; Ozawa M; Nagai H; Asai T
    Jpn J Infect Dis; 2012; 65(3):252-5. PubMed ID: 22627309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R factor-mediated antibiotic resistance in Serratia marcescens.
    Cooksey RC; Thorne GM; Farrar WE
    Antimicrob Agents Chemother; 1976 Jul; 10(1):123-7. PubMed ID: 791085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Escherichia coli mutants tolerant to bacteriocin JF246: two new classes of tolerant mutants.
    Foulds J; Barrett C
    J Bacteriol; 1973 Nov; 116(2):885-92. PubMed ID: 4583254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.